 OSN SuperSite | Sustained-release and combination therapies may be future of retinal treatment OSN SuperSite “The steroid is kind of like a shotgun, whereas the anti-VEGFs, Lucentis and Avastin, are like sniper bullets,” Dr. Haller said, noting that corticosteroids target numerous components of retinal diseases. “That is appealing, because we know that many ... |
